Differences in Mid-Term Outcomes Between Patients Undergoing Thoracic Endovascular Aortic Repair for Aneurysm or Acute Aortic Syndromes: Report From the Global Registry for Endovascular Aortic Treatment.
Daniele BissaccoMaurizio DomaninFred A WeaverAli AzizzadehCharles C MillerDennis R GableGabriele PiffarettiChiara LomazziSanti TrimarchiPublished in: Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists (2021)
Patients who underwent TEVAR for DTAA or AAS experienced different mortality and re-intervention rates among years during mid-term follow-up. Although all-cause related deaths within 30 days were TEVAR-related, aorta-related deaths were more common for AAS patients within 1 year. A greater re-intervention rate was described for AAS patients, although only 1 year after TEVAR.
Keyphrases
- end stage renal disease
- aortic dissection
- newly diagnosed
- ejection fraction
- patients undergoing
- randomized controlled trial
- aortic valve
- peritoneal dialysis
- left ventricular
- type diabetes
- pulmonary artery
- risk factors
- patient reported outcomes
- intensive care unit
- liver failure
- coronary artery disease
- pulmonary arterial hypertension
- spinal cord injury
- pulmonary hypertension
- smoking cessation